U.S. Markets closed

Thermo Fisher Scientific Inc. (TMO)

NYSE - NYSE Precio retrasado. Divisa en USD.
Añadir a la lista de seguimiento
557.87-7.36 (-1.30%)
Al cierre: 04:00PM EDT
555.00 -2.87 (-0.51%)
Fuera de horario: 06:52PM EDT

Thermo Fisher Scientific Inc.

168 Third Avenue
Waltham, MA 02451
United States
781 622 1000
https://www.thermofisher.com

Sector(es)Healthcare
IndustriaDiagnostics & Research
Empleados a tiempo completo122,000

Ejecutivos clave

NombreTítuloPagarEjecutadoAño de nacimiento
Mr. Marc N. CasperChairman, President & CEO8.01M52.48M1968
Mr. Stephen WilliamsonSenior VP & CFO2.95M12.14M1967
Mr. Michel LagardeExecutive VP & COO3.3M15.18M1975
Mr. Michael A. Boxer Esq.Senior VP & General Counsel1.76M2.9M1962
Mr. Gianluca PettitiExecutive Vice President2.11M1.82M1979
Mr. Joseph R. HolmesVP & Chief Accounting OfficerN/DN/D1980
Mr. Ryan J. SnyderSenior VP & Chief Information OfficerN/DN/DN/D
Dr. Karen E. Nelson Ph.D.Chief Scientific OfficerN/DN/DN/D
Mr. Rafael TejadaVice President of Investor RelationsN/DN/DN/D
Ms. Sandy B. PoundVP & Chief Communications OfficerN/DN/DN/D
Los importes son a partir de 31 de diciembre de 2022 y los valores de compensación son para el último año fiscal que finaliza en esa fecha. Pago corresponde al salario, las bonificaciones, etc. Ejecutado corresponde al valor de las opciones ejecutadas durante el año fiscal. Divisa en USD.

Descripción

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.

Gestión corporativa

La calificación ISS Governance QuickScore de Thermo Fisher Scientific Inc. a partir del 1 de abril de 2024 es 5. Las puntuaciones principales son Auditoría: 5; Junta: 8; Derechos del accionista: 4; Compensación: 6.

Las puntuaciones de la gestión corporativa son cortesía de Servicios de accionistas institucionales (ISS). Las puntuaciones indican una posición decil en relación con el índice o la región. Una puntuación decil 1 indica que el riesgo de gestión es menor, mientras que una puntuación decil 10 indica que el riesgo de gestión es mayor.